Search

  2. ProQR Announces Results for the Fourth Quarter and Full Year 2017 and Provides Business Update

    Press release

    … FDA Fast Track designation and ODD in the U.S. and Europe. Amylon Therapeutics was spun out as a privately-held company … candidate for Usher syndrome 2A patients, and the team at Amylon, which we spun out as a privately-owned company that … the trial in 2018 subject to a partnership. Spin-out of Amylon Therapeutics   In September, ProQR spun out Amylon …

  3. ProQR Announces Results for the Third Quarter of 2017

    Press release

    … 2018, with interim data also expected in 2018. Spin-out of Amylon Therapeutics as a privately-held company focused on … Axiomer ® .  We are also thrilled with the spin out of Amylon as a privately-held company to a group of private and … investors, while maintaining our majority ownership in Amylon. This enables the program to attract external funding …